Datopotamab Deruxtecan Improves Survival Over Chemotherapy in Patients with Previously Untreated, Locally Recurrent Inoperable or Metastatic TNBC By Ogkologos - April 28, 2026 208 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TROPION-Breast02 study Source RELATED ARTICLESMORE FROM AUTHOR FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and Chemotherapy Among Adult Patients with Ph-positive ALL Meet the first recipient of the ESMO Artificial Intelligence Fellowship MOST POPULAR The Best And Worst Face Masks For COVID-19, Plus Face Masks... August 19, 2020 Clinical Trials in Molecular Testing for Early-Stage Lung Cancer: IMpower010, ADAURA,... June 15, 2022 Making Important Decisions During Cancer: A Survivor’s Story October 26, 2021 Wine Racks and the Mystery of Survival September 16, 2022 Load more HOT NEWS Childhood cancer survivors at greater risk of ill health RANO and Modified RANO Criteria Demonstrate Similar Correlations Between PFS and... Welcome to our new committee chairs Snowboarder Wins Gold Medal At Winter Olympics After Beating Cancer
